$RARE Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Ultragenyx Pharmaceutical Inc.. Get notifications about new insider transactions in Ultragenyx Pharmaceutical Inc. for free.

Page: < prev 1 2 3 4 5 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Grant	A	0.00	2,550	0	13,550	11 K to 13.6 K (+23.18 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Option Exercise	A	76.58	4,250	325,465	4,250
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Grant	A	0.00	2,550	0	12,300	9.8 K to 12.3 K (+26.15 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Option Exercise	A	76.58	4,250	325,465	4,250
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Grant	A	0.00	2,550	0	10,425	7.9 K to 10.4 K (+32.38 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	76.58	4,250	325,465	4,250
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Grant	A	0.00	2,550	0	57,018	54.5 K to 57 K (+4.68 %)
Jun 22 2020	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Payment of Exercise	F	78.22	303	23,701	23,850	24.2 K to 23.9 K (-1.25 %)
Jun 22 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	78.22	649	50,765	26,663	27.3 K to 26.7 K (-2.38 %)
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	48.43	2,564	124,175	18,981
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	48.43	10,234	495,633	21,545
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	74.01	2,564	189,762	101,208	103.8 K to 101.2 K (-2.47 %)
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	48.43	2,564	124,175	103,772	101.2 K to 103.8 K (+2.53 %)
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	74.23	10,234	759,670	101,208	111.4 K to 101.2 K (-9.18 %)
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	48.43	10,234	495,633	111,442	101.2 K to 111.4 K (+10.11 %)
Jun 03 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	74.02	20,000	1,480,322	70,350	90.4 K to 70.4 K (-22.14 %)
Jun 03 2020	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	69.38	262	18,178	34,961	35.2 K to 35 K (-0.74 %)
Jun 03 2020	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	69.38	262	18,178	49,341	49.6 K to 49.3 K (-0.53 %)
Jun 03 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	69.38	348	24,144	101,208	101.6 K to 101.2 K (-0.34 %)
Jun 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	69.38	348	24,144	101,740	102.1 K to 101.7 K (-0.34 %)
Jun 03 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	69.38	1,334	92,553	611,041	612.4 K to 611 K (-0.22 %)
May 27 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	74.93	260	19,482	18,331	18.6 K to 18.3 K (-1.40 %)
May 27 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Payment of Exercise	F	73.81	433	31,960	18,591	19 K to 18.6 K (-2.28 %)
May 22 2020	RARE	Ultragenyx Pharmac ...	Ultragenyx Pharmaceutical Inc.	Director	Option Exercise	M	16.00	600,000	9,600,000	0
May 22 2020	RARE	Ultragenyx Pharmac ...	Ultragenyx Pharmaceutical Inc.	Director	Buy	M	16.00	600,000	9,600,000	3,000,000	2.4 M to 3 M (+25.00 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	M	40.37	7,500	302,775	0
May 20 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	74.65	7,500	559,875	47,924	55.4 K to 47.9 K (-13.53 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	M	40.37	7,500	302,775	55,424	47.9 K to 55.4 K (+15.65 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	70.57	3,907	275,717	500
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	48.43	3,221	155,993	31,779
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	70.57	19,593	1,382,678	4,407
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.32	3,907	286,461	101,556	105.5 K to 101.6 K (-3.70 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	70.57	3,907	275,717	104,851	100.9 K to 104.9 K (+3.87 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.32	3,221	236,164	100,944	104.2 K to 100.9 K (-3.09 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	48.43	3,221	155,993	104,165	100.9 K to 104.2 K (+3.19 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.29	2,392	175,310	100,944	103.3 K to 100.9 K (-2.31 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.34	19,593	1,436,951	103,336	122.9 K to 103.3 K (-15.94 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	70.57	19,593	1,382,678	122,929	103.3 K to 122.9 K (+18.96 %)
May 19 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Option Exercise	M	21.00	1,500	31,500	15,500
May 19 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	71.00	1,500	106,500	19,024	20.5 K to 19 K (-7.31 %)
May 19 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Buy	M	21.00	1,500	31,500	20,219	18.7 K to 20.2 K (+8.01 %)
May 19 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	71.00	961	68,231	18,719	19.7 K to 18.7 K (-4.88 %)
May 19 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	75.00	1,875	140,625	11,000	12.9 K to 11 K (-14.56 %)
May 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	74.72	2,722	203,374	27,312	30 K to 27.3 K (-9.06 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	66.26	248	16,432	34,979	35.2 K to 35 K (-0.70 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Payment of Exercise	F	66.26	138	9,144	19,680	19.8 K to 19.7 K (-0.70 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	66.26	852	56,454	652,797	653.6 K to 652.8 K (-0.13 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	66.26	248	16,432	101,675	101.9 K to 101.7 K (-0.24 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	66.26	248	16,432	29,904	30.2 K to 29.9 K (-0.82 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	66.26	248	16,432	48,991	49.2 K to 49 K (-0.50 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	66.26	248	16,432	103,336	103.6 K to 103.3 K (-0.24 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Payment of Exercise	F	66.26	249	16,499	36,051	36.3 K to 36.1 K (-0.69 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Payment of Exercise	F	66.26	209	13,848	24,153	24.4 K to 24.2 K (-0.86 %)
Apr 24 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	65.00	1,875	121,875	12,875	14.8 K to 12.9 K (-12.71 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	58.57	248	14,525	103,584	103.8 K to 103.6 K (-0.24 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	58.57	248	14,525	49,239	49.5 K to 49.2 K (-0.50 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	58.57	248	14,525	30,152	30.4 K to 30.2 K (-0.82 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	58.57	248	14,525	101,923	102.2 K to 101.9 K (-0.24 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	58.57	851	49,843	653,649	654.5 K to 653.6 K (-0.13 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Payment of Exercise	F	58.57	140	8,200	19,818	20 K to 19.8 K (-0.70 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	58.57	248	14,525	35,227	35.5 K to 35.2 K (-0.70 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Payment of Exercise	F	58.57	210	12,300	24,362	24.6 K to 24.4 K (-0.85 %)
Mar 13 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Option Exercise	X	3.01	66,533	199,998	0
Mar 13 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Option Exercise	X	3.01	83,167	250,000	0
Mar 13 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Buy	X	3.01	66,533	199,998	654,500	588 K to 654.5 K (+11.32 %)
Mar 13 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Buy	X	3.01	83,167	250,000	587,967	504.8 K to 588 K (+16.48 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Option Exercise	A	56.08	22,000	1,233,760	22,000
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Payment of Exercise	F	56.08	824	46,210	24,572	25.4 K to 24.6 K (-3.24 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Grant	A	0.00	3,287	0	25,396	22.1 K to 25.4 K (+14.87 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Grant	A	0.00	7,800	0	22,109	14.3 K to 22.1 K (+54.51 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	A	56.08	22,000	1,233,760	22,000
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	56.08	2,118	118,777	30,400	32.5 K to 30.4 K (-6.51 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	5,634	0	32,518	26.9 K to 32.5 K (+20.96 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	7,800	0	26,884	19.1 K to 26.9 K (+40.87 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Option Exercise	A	56.08	56,100	3,146,088	56,100
Mar 03 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	56.08	6,896	386,728	504,800	511.7 K to 504.8 K (-1.35 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	18,782	0	511,696	492.9 K to 511.7 K (+3.81 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	17,000	0	492,914	475.9 K to 492.9 K (+3.57 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Option Exercise	A	56.08	7,480	419,478	7,480
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Payment of Exercise	F	56.08	388	21,759	17,058	17.4 K to 17.1 K (-2.22 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Grant	A	0.00	1,500	0	17,446	15.9 K to 17.4 K (+9.41 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Option Exercise	A	56.08	22,000	1,233,760	22,000
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	56.08	1,779	99,766	35,475	37.3 K to 35.5 K (-4.78 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	5,634	0	37,013	31.4 K to 37 K (+17.95 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	7,800	0	31,379	23.6 K to 31.4 K (+33.08 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Option Exercise	A	56.08	22,000	1,233,760	22,000
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	56.08	3,085	173,007	49,487	46.4 K to 49.5 K (+6.65 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	5,634	0	52,572	46.9 K to 52.6 K (+12.00 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	7,800	0	46,938	39.1 K to 46.9 K (+19.93 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	56.08	20,000	1,121,600	20,000
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	56.08	2,067	115,917	102,171	104.2 K to 102.2 K (-1.98 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	5,634	0	104,109	98.5 K to 104.1 K (+5.72 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	6,800	0	98,475	91.7 K to 98.5 K (+7.42 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	56.08	2,325	130,386	103,832	106.2 K to 103.8 K (-2.19 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	5,634	0	106,157	100.5 K to 106.2 K (+5.60 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	A	56.08	21,000	1,177,680	21,000
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Payment of Exercise	F	56.08	1,249	70,044	36,300	37.5 K to 36.3 K (-3.33 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	5,634	0	37,549	31.9 K to 37.5 K (+17.65 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	7,300	0	31,915	24.6 K to 31.9 K (+29.66 %)
Jan 31 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Payment of Exercise	F	53.23	1,624	86,446	24,615	26.2 K to 24.6 K (-6.19 %)
Jan 15 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	61.00	1,000	61,000	15,946	16.9 K to 15.9 K (-5.90 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Grant	A	0.00	1,208	0	14,309	13.1 K to 14.3 K (+9.22 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	1,434	0	23,579	22.1 K to 23.6 K (+6.48 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	3,435	0	475,914	472.5 K to 475.9 K (+0.73 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	1,434	0	91,675	90.2 K to 91.7 K (+1.59 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	1,434	0	19,084	17.7 K to 19.1 K (+8.12 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	1,434	0	39,138	37.7 K to 39.1 K (+3.80 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	1,434	0	100,523	99.1 K to 100.5 K (+1.45 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	1,437	0	26,239	24.8 K to 26.2 K (+5.79 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Grant	A	0.00	800	0	16,785	16 K to 16.8 K (+5.00 %)
Oct 07 2019	RARE	Ultragenyx Pharmac ...	Hogenhuis Wladimir	Chief Operating Off ...	Payment of Exercise	F	44.52	1,297	57,742	18,703	20 K to 18.7 K (-6.48 %)
Oct 07 2019	RARE	Ultragenyx Pharmac ...	Hogenhuis Wladimir	Chief Operating Off ...	Payment of Exercise	F	44.52	1,297	57,742	18,703	20 K to 18.7 K (-6.48 %)
Sep 17 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	6.86	24,880	170,677	2,998
Sep 17 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.81	6,963	5,640	0
Sep 17 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	6.86	24,880	170,677	99,089	74.2 K to 99.1 K (+33.53 %)
Sep 17 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.81	6,963	5,640	74,209	67.2 K to 74.2 K (+10.35 %)
Sep 11 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Buy	P	43.63	5,000	218,150	472,479	467.5 K to 472.5 K (+1.07 %)
Sep 11 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Buy	P	43.63	5,000	218,150	472,479	467.5 K to 472.5 K (+1.07 %)
Jul 17 2019	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	59.17	649	38,401	37,704	38.4 K to 37.7 K (-1.69 %)
Jul 09 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Payment of Exercise	F	59.51	260	15,473	13,101	13.4 K to 13.1 K (-1.95 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	61.50	1,226	75,399	17,650	18.9 K to 17.7 K (-6.50 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	63.01	1,489	93,822	18,876	20.4 K to 18.9 K (-7.31 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	63.48	649	41,199	20,365	21 K to 20.4 K (-3.09 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	61.50	1,226	75,399	17,650	18.9 K to 17.7 K (-6.50 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	63.01	1,489	93,822	18,876	20.4 K to 18.9 K (-7.31 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	63.48	649	41,199	20,365	21 K to 20.4 K (-3.09 %)
Jun 21 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Option Exercise	A	63.27	12,000	759,240	12,000
Jun 21 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Grant	A	0.00	3,500	0	13,361	9.9 K to 13.4 K (+35.49 %)
Jun 21 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Option Exercise	A	63.27	12,000	759,240	12,000
Jun 21 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Grant	A	0.00	3,500	0	13,361	9.9 K to 13.4 K (+35.49 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Grant	A	0.00	3,000	0	47,924	44.9 K to 47.9 K (+6.68 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	SULIMAN SHEHNAAZ	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	SULIMAN SHEHNAAZ	Director	Grant	A	0.00	3,000	0	3,000	0 to 3 K
Jun 13 2019	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Grant	A	0.00	3,000	0	9,750	6.8 K to 9.8 K (+44.44 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Grant	A	0.00	3,000	0	9,750	6.8 K to 9.8 K (+44.44 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Grant	A	0.00	3,000	0	9,750	6.8 K to 9.8 K (+44.44 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Grant	A	0.00	3,000	0	14,750	11.8 K to 14.8 K (+25.53 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Grant	A	0.00	3,000	0	9,750	6.8 K to 9.8 K (+44.44 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Grant	A	0.00	3,000	0	7,875	4.9 K to 7.9 K (+61.54 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	54.93	1,327	72,892	467,479	468.8 K to 467.5 K (-0.28 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	54.93	346	19,006	90,241	90.6 K to 90.2 K (-0.38 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	54.93	260	14,282	38,353	38.6 K to 38.4 K (-0.67 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	54.93	260	14,282	22,145	22.4 K to 22.1 K (-1.16 %)

Page: < prev 1 2 3 4 5 5 next >